Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.
| 22 Mar 2022 | |
| Written by Rashad Ismayilzada | |
| General |
Finnish venture capital firm Innovestor has launched a new Life Science & Health fund focusing on early-stage opportunities in the Nordic and Baltic countries. The fund has completed a first closing of € 60 million and aims to increase its capital to 90-120 million euros within 12 months. State-backed Finnish Industry Investment (Tesi) acts as anchor investor in the fund. The new fund aims to find the next billion dollar innovations from universities and strong research-based companies. A team of accomplished professionals from the sector is responsible for fund investments.
Read more at:
